Zinc level and its impact on the phenotype of sickle cell disease
Annals of Hematology · 2025
DOI: 10.1007/s00277-025-06429-4 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Annals of Hematology, 2025. Verfasst von Ilham Youssry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Pediatric Hematology and Bone Marrow Transplantation, Kasr Alainy Faculty of Medicine, Cairo University, 2 Tayseer Street, …. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Zinc, Zinc Sulfate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Zinc is an important antioxidant, and its deficiency contributes to oxidative damage in sickle cell disease (SCD). Emerging evidence supports zinc’s beneficial effects on SCD phenotype. This study aimed to determine the prevalence of zinc deficiency and assess the impact of zinc supplementation on clinical, hematological, and oxidative parameters in SCD children. Sixty SCD children were enrolled in this single-arm prospective study. All participants received daily oral zinc sulfate for 12 months [10 mg for ages 4–8, 20 mg for ages 9–13, and 30 mg for ages 14–18]. Clinical assessments and laboratory evaluations, including serum zinc, copper, nitric oxide, and total antioxidant activity, were conducted at baseline and after 12 months. The patients’ mean age was 9.2 ± 4.1 years; 80% had HbSS and 20% had sickle β-thalassemia. All patients were zinc-deficient at baseline (mean zinc: 42.8 ± 14.1 µg/dl). Post-supplementation, there were significant improvements in weight and height Z-scores (p-values < 0.001), and reductions in the frequency of vaso-occlusive crises, infections, hospitalizations, and transfusions (p-values < 0.001). Significant increases were observed in hemoglobin, hematocrit, fetal hemoglobin, zinc, nitric oxide, and total antioxidant activity (p-values < 0.001, < 0.001, 0.001, < 0.001, < 0.001, and < 0.001 respectively), while serum bilirubin, ferritin, and copper levels decreased significantly (p-values = 0.029, < 0.001, and 0.009, respectively). Zinc deficiency appears highly prevalent among SCD children, and supplementation may offer clinical, hematological, and antioxidant benefits. This study highlights the potential beneficial effects of zinc in this high-risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Pediatric Hematology and Bone Marrow Transplantation, Kasr Alainy Faculty of Medicine, Cairo University, 2 Tayseer Street, End of King Faisal Street, Giza, Egypt.
- Department of Medical Biochemistry, Medical Research Division, National Research Centre, Giza, Egypt.
- Department of Pediatrics, El-Galaa Teaching Hospital, Cairo, Egypt.
- Department of Pediatrics, Pediatric Hematology and Bone Marrow Transplantation, Kasr Alainy Faculty of Medicine, Cairo University, 2 Tayseer Street, End of King Faisal Street, Giza, Egypt. yasmeenselim87@gmail.com.
Förderung
- Cairo University
Zitieren
APA
Youssry, I., El-Ghamrawy, M., Youness, E. R., Mohamed, N. A., & Selim, Y. M. M. (2025). Zinc level and its impact on the phenotype of sickle cell disease. Annals of Hematology. https://doi.org/10.1007/s00277-025-06429-4
Vancouver
Youssry I, El-Ghamrawy M, Youness ER, Mohamed NA, Selim YMM. Zinc level and its impact on the phenotype of sickle cell disease. Annals of Hematology. 2025. doi:10.1007/s00277-025-06429-4
BibTeX
@article{Youssry2025,
author = {Youssry, Ilham and El-Ghamrawy, Mona and Youness, Eman R and Mohamed, Nahla A and Selim, Yasmeen Mohammed Mahmoud},
title = {Zinc level and its impact on the phenotype of sickle cell disease},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-025-06429-4}
}
EUVIMED